Plasma miRNA signature for the diagnosis of pulmonary tuberculosis in symptomatic patients
Abstract
Background: The prompt and precise diagnosis of active pulmonary tuberculosis (TB) is crucial for controlling this disease and yet it remains a global challenge. The objective of this study was to identify a set of microRNAs (miRNAs) whose expression in plasma could be used as a triage test for diagnosing TB. Methods: A total of 879 plasma samples were collected in seven clinical centres from healthy individuals and patients displaying TB-like symptoms and/or radiological features consistent with TB. The samples were classified as TB, pneumonia, lung cancer and HC subgroups based on subsequent diagnostic assessments. We performed quantitative profiling of 264 plasma miRNAs in a training cohort (n=410) and an independent external test cohort (n=469). After dimensionality reduction and feature selection analysis, we identified nine discriminative miRNAs and used them to train an ensemble model in a training cohort using the scikit-learn library, which was subsequently evaluated in the external test cohort. Results: The ensemble model showed notable accuracy in discriminating TB from non-TB patients, yielding areas under the curve (AUC) of 0.84 (95% CI 0.80 to 0.88) for the training cohort and 0.86 (95% CI 0.82 to 0.90) for the external test cohort. When tested against subgroups of laboratory confirmed and clinically diagnosed but unconfirmed TB, the AUC values were 0.89 (95% CI 0.85 to 0.93) and 0.83 (95% CI 0.79 to 0.88), respectively. In smear-negative confirmed TB patients, the AUC exceeded 0.83, with a sensitivity and specificity of 0.75. Conclusions: Our miRNA ensemble model, based on detecting a nine-miRNA expression biosignature in plasma, demonstrated promising ability to diagnose TB and distinguish it from other common lung diseases but further studies are needed to assess its clinical applicability. Trial registration number: ChiCTR2000039734.Keywords
Funding Information
- The 2024 High-quality Development Research Project of Shenzhen Bao’an Public Hospital (BAGZL2024040)
- National Natural Science Foundation of China (82372323)
- National Natural Science Foundation of China (82430074)
- Shenzhen Medical Research Special Fund Project (A2304001)
- Guangdong Provincial Science and Technology Program (2019B030301009)
- Shenzhen Science and Technology Innovation Foundation (2023B005)
- Shenzhen Science and Technology Innovation Foundation (CJGJZD20220517141404010/2023B005)
- Shenzhen Science and Technology Innovation Foundation (JCY20220530142801003)
- Shenzhen Science and Technology Innovation Foundation (JCYJ20220530160207015)
- Shenzhen Science and Technology Innovation Foundation (JSGGZD20220822095200001)
- Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project (2025ZD01907201)
- Provincial Natural Science Foundation of Guangdong (2022A1515012438)
- Provincial Natural Science Foundation of Guangdong (2022A1515220034)
This publication has 33 references indexed in Scilit:
- Update on the diagnosis of tuberculosisClinical Microbiology and Infection, 2023
- Neuro-immune Interactions in the TissuesImmunity, 2020
- Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: a diagnostic accuracy studyThe Lancet Infectious Diseases, 2019
- Factors Associated With Sputum Culture-Negative vs Culture-Positive Diagnosis of Pulmonary TuberculosisJAMA Network Open, 2019
- Assessment of Validity of a Blood-Based 3-Gene Signature Score for Progression and Diagnosis of Tuberculosis, Disease Severity, and Treatment ResponseJAMA Network Open, 2018
- Screening and identification of four serum miRNAs as novel potential biomarkers for cured pulmonary tuberculosisTuberculosis, 2018
- Diagnostic Test Accuracy of a 2-Transcript Host RNA Signature for Discriminating Bacterial vs Viral Infection in Febrile ChildrenJAMA, 2016
- A blood RNA signature for tuberculosis disease risk: a prospective cohort studyThe Lancet, 2016
- MicroRNA let-7 Modulates the Immune Response to Mycobacterium tuberculosis Infection via Control of A20, an Inhibitor of the NF-κB PathwayCell Host & Microbe, 2015
- Differential expression of miRNAs by macrophages infected with virulent and avirulent Mycobacterium tuberculosisTuberculosis, 2013